Role of Adipokines in Obesity and Obesity related Metabolic Disorders-Reference-Cited by-同舟云学术

Role of Adipokines in Obesity and Obesity related Metabolic Disorders

Published:2021-08-06 Issue: Volume: Page:4261-4264
ISSN:0974-360X
Container-title:Research Journal of Pharmacy and Technology
language:en
Short-container-title:RJPT

Author:

Govindaraj Jayamathi¹,Govindaraj Keerthidaa²,Jayesh S. Raghavendra³,Padmavathy Kesavaram⁴,Ramalingam Mathangi⁵,U. Vidyarekha⁶

Affiliation:

1. Professor, Department of Biochemistry, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Pallikaranai, Chennai, 600100, India.

2. MDS Department of Periodontics, Thai Mookambihai Dental College and Hospital, MGR University, Maduravoyal, Chennai, India.

3. Professor, Department of Prosthodontics, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, (BIHER) Pallikaranai, Chennai, 600100, India.

4. Associate Professor, Department of Microbiology, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Pallikaranai, Chennai, 600100, India.

5. Professor, Department of Biochemistry, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, (BIHER) Pallikaranai, Chennai, 600100, India.

6. Senior Lecturer in Public Health Dentistry, Sree Balaji Dental College and Hospital, Bharath institute of Higher Education and Research, Pallikaaranai, Chennai, 600100, India.

Abstract

Obesity is defined as an excessive growth of adipose tissue. It is associated with over nutrition, which impairs systemic metabolic homeostasis. Adipokines secreted by adipose tissue could play an vital role in the development of obesity and associated metabolic disorders includes insulin resistance, inflammation, hypertension, cardiovascular risk etc. Adipokines will be of importance in the development of novel therapies for obesity-associated diseases. This review emphasises on obesity and the role of some Adipokines in obesity and related metabolic disorders.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference18 articles.

1. Reaven G, Abbasi F, Mc. Laughlin T. Obesity, insulin resistance and cardiovascular disease. Recent Prog Horm Res. 2004; 59: 207-23.

2. Xu H, Barnes G.T, Yang, Q, Tan G, Yang D, Chou C.J, Sole J. Nichols A, Ross JS, Tartaglia LA. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 2003; 112: 1821-1830.

3. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol. 2004; 89: 2548-56.

4. Aldhahi W and Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Current Diabetes Reports. 2003; 3(4): 293-298.

5. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous adipose tissues of obese humans. Endocrinology. 2004; 14: 52273-82.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compendious Review on Adipokines of Corpulence;Research Journal of Pharmacy and Technology;2022-09-28